<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">69578</article-id><article-id pub-id-type="doi">10.7554/eLife.69578</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group></article-categories><title-group><article-title>Innate immune activation by checkpoint inhibition in human patient-derived lung cancer tissues</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-235181"><name><surname>Fan</surname><given-names>Teresa</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7292-8938</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-157214"><name><surname>Higashi</surname><given-names>Richard M</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-238470"><name><surname>Song</surname><given-names>Huan</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-238471"><name><surname>Daneshmandi</surname><given-names>Saeed</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-238477"><name><surname>Mahan</surname><given-names>Angela L</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-238472"><name><surname>Purdom</surname><given-names>Matthew S</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-238473"><name><surname>Bocklage</surname><given-names>Therese J</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-238474"><name><surname>Pittman</surname><given-names>Thomas A</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-238475"><name><surname>He</surname><given-names>Daheng</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-238476"><name><surname>Wang</surname><given-names>Chi</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-151832"><name><surname>Lane</surname><given-names>Andrew N</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution>University of Kentucky</institution>, <addr-line><named-content content-type="city">LEXINGTON</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Department of Toxicology and Cancer Biology</institution>, <institution>University of Kentucky</institution>, <addr-line><named-content content-type="city">Lexington</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution>Baptist Health</institution>, <addr-line><named-content content-type="city">Louisville</named-content></addr-line>, <country>United States</country></aff><aff id="aff4"><institution content-type="dept">Deptartment of Pathology and Laboratory Medicine</institution>, <institution>University of Kentucky</institution>, <addr-line><named-content content-type="city">Lexington</named-content></addr-line>, <country>United States</country></aff><aff id="aff5"><institution content-type="dept">Department of Neurosurgery</institution>, <institution>University of Kentucky</institution>, <addr-line><named-content content-type="city">Lexington</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-146013"><name><surname>Malavasi</surname><given-names>Fabio</given-names></name><role>Reviewing editor</role><aff><institution>University of Torino Medical School</institution>, <country>Italy</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>teresa.fan@uky.edu</email> (TF);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>andrew.lane@uky.edu</email> (AL);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>18</day><month>08</month><year>2021</year></pub-date><volume>10</volume><elocation-id>e69578</elocation-id><history><date date-type="received"><day>20</day><month>04</month><year>2021</year></date><date date-type="accepted"><day>26</day><month>07</month><year>2021</year></date></history><permissions><copyright-statement>Â© 2021, Fan et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Fan et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-69578-v3.pdf"/><abstract><p>Although Pembrolizumab-based immunotherapy has significantly improved lung cancer patient survival, many patients show variable efficacy and resistance development. A better understanding of the drug's action is needed to improve patient outcomes. Functional heterogeneity of the tumor microenvironment (TME) is crucial to modulating drug resistance; understanding of individual patients' TME that impacts drug response is hampered by lack of appropriate models. Lung organotypic tissue slice cultures (OTC) with patients' native TME procured from primary and brain-metastasized (BM) non-small cell lung cancer (NSCLC) patients were treated with Pembrolizumab and/or beta-glucan (WGP, an innate immune activator). Metabolic tracing with<sup> 13</sup>C<sub>6</sub>-Glc/<sup>13</sup>C<sub>5,</sub><sup>15</sup>N<sub>2</sub>-Gln, multiplex immunofluorescence (mIF), and digital spatial profiling (DSP) were employed to interrogate metabolic and functional responses to Pembrolizumab and/or WGP. Primary and BM PD-1<sup>+</sup> lung cancer OTC responded to Pembrolizumab and Pembrolizumab + WGP treatments, respectively. Pembrolizumab activated innate immune metabolism and functions in primary OTC, which were accompanied by tissue damage. DSP analysis indicated an overall decrease in immunosuppressive macrophages and T cells but revealed microheterogeneity in immune responses and tissue damage. Two TMEs with altered cancer cell properties showed resistance. Pembrolizumab or WGP alone had negligible effects on BM-lung cancer OTC but Pembrolizumab + WGP blocked central metabolism with increased pro-inflammatory effector release and tissue damage. In depth metabolic analysis and multiplex TME imaging of lung cancer OTC demonstrated overall innate immune activation by Pembrolizumab but heterogeneous responses in the native TME of a patient with primary NSCLC. Metabolic and functional analysis also revealed synergistic action of Pembrolizumab and WGP in OTC of metastatic NSCLC.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: Surgical patients were consented for freshly resected tissue specimens under the approved IRB protocol (14-0288-F6A; 13-LUN-94-MCC) of the University of Kentucky (UKy).</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files. Excel spreadsheets of data used for tables and figures will be deposited at Dryad.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Fan TWM et al</collab></person-group><year iso-8601-date="2021">2021</year><source>data from: Innate immune activation by checkpoint inhibition in patient-derived lung cancer tissues</source><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.5061/dryad.n5tb2rbwc">http://dx.doi.org/10.5061/dryad.n5tb2rbwc</ext-link><comment>Dryad Digital Repository, doi:10.5061/dryad.n5tb2rbwc</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-69578-supp-v3.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>